Medicare Part D

Despite restraints, Democrats’ drug pricing plan could still aid consumers

BY: - November 8, 2021

By Michael McAuliff, Kaiser Health News The Medicare prescription drug pricing plan Democrats unveiled this week is not nearly as ambitious as many lawmakers sought, but they and drug policy experts say the provisions crack open the door to reforms that could have dramatic effects. Tamping down drug expenses has been a longtime rallying cry for consumers beset […]

COMMENTARY

2+2=? Senate uses murky math as it shelves drug pricing rule to fund infrastructure

BY: - August 6, 2021

By Michael McAuliff, Kaiser Health News The Senate’s release of its bipartisan infrastructure plan signals that lawmakers are poised to throw former President Donald Trump’s belated bid to lower Medicare drug prices under the bus — not to mention trains, bridges, tunnels and broadband connections. That’s because the massive spending bill is the first of […]